Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.'. Together they form a unique fingerprint.

Medicine & Life Sciences